Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1747-597X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: a preliminary study ; volume:12 ; number:1 ; day:15 ; month:11 ; year:2017 ; pages:1-7 ; date:12.2017
Substance abuse treatment, prevention, and policy ; 12, Heft 1 (15.11.2017), 1-7, 12.2017
- Classification
-
Medizin, Gesundheit
- Creator
-
Scott, Travis M.
- Contributor
-
Rivera Mindt, Monica
Cunningham, Chinazo O.
Arias, Franchesca
Coulehan, Kelly
Mangalonzo, Aprille
Olsen, Pat
Arnsten, Julia H.
SpringerLink (Online service)
- DOI
-
10.1186/s13011-017-0133-2
- URN
-
urn:nbn:de:1111-201801172373
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Scott, Travis M.
- Rivera Mindt, Monica
- Cunningham, Chinazo O.
- Arias, Franchesca
- Coulehan, Kelly
- Mangalonzo, Aprille
- Olsen, Pat
- Arnsten, Julia H.
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Expansion of opiate agonist treatment: an historical perspective
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Expansion of opiate agonist treatment: an historical perspective
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
A comparison of sexual desire in opiate-dependent men receiving methadone and buprenorphine maintenance treatment
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Expansion of opiate agonist treatment: an historical perspective
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach